Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much?
Heart failure (HF) is a major public health problem characterised by a high rate of hospitalisation and death. The risk is maximal for patients admitted with acute heart failure (AHF). New therapies with solid proof of mortality reduction in both groups of patients with reduced and preserved ejectio...
Saved in:
Main Author: | Nechita Alexandru Cristian (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calcifediol: Why, When, How Much?
by: Simone Donati, et al.
Published: (2023) -
Treatment of phosphate retention: The earlier the better?
by: Patrick Biggar, et al.
Published: (2014) -
Earlier surgical intervention in congenital heart disease results in better outcome and resource utilization
by: Panni Roheena Z, et al.
Published: (2011) -
Blood component therapy: Which, when and how much
by: Rajesh Chand Arya, et al.
Published: (2011) -
Protein for Preterm Infants: How Much is Needed? How Much is Enough? How Much is Too Much?
by: William W. Hay, et al.
Published: (2010)